TOP

Research Article

Split Viewer

Mol. Cells 2009; 27(4): 417-422

Published online April 13, 2009

https://doi.org/10.1007/s10059-009-0059-2

© The Korean Society for Molecular and Cellular Biology

Lipoxygenase Inhibitors Suppressed Carra-geenan-Induced Fos-Expression and Inflammatory Pain Responses in the Rat

Sungjae Yoo, Shanshu Han, Young Shin Park, Jang-Hern Lee, Uhtaek Oh, and Sun Wook Hwang

Received: December 17, 2009; Revised: February 14, 2009; Accepted: March 4, 2009

Abstract

Lipoxygenase (LO) metabolites are generated in inflamed tissues. However, it is unclear whether the inhibition of the LO activity regulates the expression of c-Fos protein, a pain marker in the spinal cord. Here we used a carrageenan-induced inflammation model to examine the role of LO in the development of c-Fos expression. Intradermally injected carrageenan caused elevated number of cells exhibiting Fos-like immunoreactivity (Fos-LI) in the spinal dorsal horn, and decreased the thermal and mechanical threshold in Hargreaves and von Frey tests. Pretreatment with an inhibitor of phospholipase A2, that generates the LO substrate, prior to the carrageenan injection significantly reduced the number of Fos-(+) cells. A general LO inhibitor NDGA, a 5-LO inhibitor AA-861 and a 12-LO inhibitor baicalein also exhibited the similar effects. Moreover, the LO inhibitors suppressed carrageenan-induced thermal and mechanical hyperalgesic behaviors, which inidcates that the changes in Fos expression correlates with those in the nociceptive behaviors in the inflamed rats. LO products are endogenous TRPV1 activators and pretreat-ment with BCTC, a TRPV1 antagonist inhibited the thermal but not the mechanical hypersensitivity. Overall, our results from the Fos-LI and behavior tests suggest that LO products released from inflamed tissues contribute to nociception during carrageenan-induced inflammation, in-dicating that the LO pathway is a possible target for modulating inflammatory pain.

Keywords Fos immunohystochemistry, inflammation, lipoxygenase, pain, TRPV1

Article

Research Article

Mol. Cells 2009; 27(4): 417-422

Published online April 30, 2009 https://doi.org/10.1007/s10059-009-0059-2

Copyright © The Korean Society for Molecular and Cellular Biology.

Lipoxygenase Inhibitors Suppressed Carra-geenan-Induced Fos-Expression and Inflammatory Pain Responses in the Rat

Sungjae Yoo, Shanshu Han, Young Shin Park, Jang-Hern Lee, Uhtaek Oh, and Sun Wook Hwang

Received: December 17, 2009; Revised: February 14, 2009; Accepted: March 4, 2009

Abstract

Lipoxygenase (LO) metabolites are generated in inflamed tissues. However, it is unclear whether the inhibition of the LO activity regulates the expression of c-Fos protein, a pain marker in the spinal cord. Here we used a carrageenan-induced inflammation model to examine the role of LO in the development of c-Fos expression. Intradermally injected carrageenan caused elevated number of cells exhibiting Fos-like immunoreactivity (Fos-LI) in the spinal dorsal horn, and decreased the thermal and mechanical threshold in Hargreaves and von Frey tests. Pretreatment with an inhibitor of phospholipase A2, that generates the LO substrate, prior to the carrageenan injection significantly reduced the number of Fos-(+) cells. A general LO inhibitor NDGA, a 5-LO inhibitor AA-861 and a 12-LO inhibitor baicalein also exhibited the similar effects. Moreover, the LO inhibitors suppressed carrageenan-induced thermal and mechanical hyperalgesic behaviors, which inidcates that the changes in Fos expression correlates with those in the nociceptive behaviors in the inflamed rats. LO products are endogenous TRPV1 activators and pretreat-ment with BCTC, a TRPV1 antagonist inhibited the thermal but not the mechanical hypersensitivity. Overall, our results from the Fos-LI and behavior tests suggest that LO products released from inflamed tissues contribute to nociception during carrageenan-induced inflammation, in-dicating that the LO pathway is a possible target for modulating inflammatory pain.

Keywords: Fos immunohystochemistry, inflammation, lipoxygenase, pain, TRPV1

Mol. Cells
Nov 30, 2023 Vol.46 No.11, pp. 655~725
COVER PICTURE
Kim et al. (pp. 710-724) demonstrated that a pathogen-derived Ralstonia pseudosolanacearum type III effector RipL delays flowering time and enhances susceptibility to bacterial infection in Arabidopsis thaliana. Shown is the RipL-expressing Arabidopsis plant, which displays general dampening of the transcriptional program during pathogen infection, grown in long-day conditions.

Share this article on

  • line

Related articles in Mol. Cells

Molecules and Cells

eISSN 0219-1032
qr-code Download